Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?-Reference-Cited by-同舟云学术

Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?

Published:2017-01-20 Issue:4 Volume:115 Page:376-383
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Xia Brent T.¹,Fu Baojin²,Wang Jiang²,Kim Young¹,Ahmad S. Ameen¹,Dhar Vikrom K.¹,Levinsky Nick C.¹,Hanseman Dennis J.¹,Habib David A.¹,Wilson Gregory C.¹,Smith Milton³,Olowokure Olugbenga O.⁴,Kharofa Jordan⁵,Al Humaidi Ali H.¹,Choe Kyuran A.⁶,Abbott Daniel E.⁷,Ahmad Syed A.¹

Affiliation:

1. Division of Surgical Oncology, Department of Surgery; University of Cincinnati; Cincinnati Ohio

2. Department of Pathology; University of Cincinnati; Cincinnati Ohio

3. Division of Gastroenterology, Department of Internal Medicine; University of Cincinnati; Cincinnati Ohio

4. Division of Medical Oncology, Department of Internal Medicine; University of Cincinnati; Cincinnati Ohio

5. Department of Radiation Oncology; University of Cincinnati; Cincinnati Ohio

6. Department of Radiology; University of Cincinnati; Cincinnati Ohio

7. Division of Surgical Oncology, Department of Surgery; Univesity of Wisconsin; Madison Wisconsin

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference29 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators;Sohn;J Gastrointest Surg,2000

3. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease;Katz;J Am Coll Surg,2008

4. Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A 0211 01;Katz;JAMA Surg,2016

5. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas;Pingpank;J Gastrointest Surg,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Primary Pancreatic Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review;Annals of Surgical Oncology;2023-04-05

3. Imaging Recommendations for Diagnosis, Staging, and Management of Pancreatic Cancer;Indian Journal of Medical and Paediatric Oncology;2023-02

4. Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels;HPB;2023-01

5. What Can We Learn About Pancreatic Adenocarcinoma from Imaging?;Hematology/Oncology Clinics of North America;2022-10